ICD-10 Code B38.7 | Disseminated coccidioidomycosis Symptoms, Diagnosis, Billing

Disseminated coccidioidomycosis is a systemic fungal infection caused by the Coccidioides species, primarily affecting individuals with compromised immune systems. It can lead to severe complications, including meningitis and disseminated disease affecting multiple organs. Accurate coding with ICD-10 Code B38.7 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this serious condition effectively.

What is ICD-10 Code B38.7 for Disseminated coccidioidomycosis?

ICD-10 Code B38.7 represents disseminated coccidioidomycosis, a severe form of coccidioidomycosis where the infection spreads beyond the lungs to other parts of the body. This code should be used when documenting cases of disseminated disease, particularly in patients with underlying immunosuppression or those presenting with systemic symptoms, to ensure accurate billing and appropriate treatment.

ICD-10 Code B38.7 – Clinical Definition and Explanation of Disseminated coccidioidomycosis

Disseminated coccidioidomycosis occurs when the Coccidioides fungus spreads from the lungs to other organs, often resulting in severe illness. It is commonly seen in immunocompromised patients and can lead to life-threatening complications. Prompt recognition and treatment are crucial to prevent morbidity and mortality.

Key Clinical Features:

• Fever and chills, indicating systemic infection.
• Respiratory symptoms such as cough and chest pain.
• Neurological manifestations, including headache and confusion.
• Skin lesions or rashes in disseminated cases.

ICD-10 Code B38.7 for Disseminated coccidioidomycosis – SOAP Notes & Clinical Use

ICD-10 Code B38.7 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of disseminated coccidioidomycosis. It plays a vital role in capturing the severity of the condition and guiding appropriate management strategies in both acute and chronic care settings.

What Does ICD-10 Code B38.7 for Disseminated coccidioidomycosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B38.7 connects subjective patient reports and objective clinical findings to a formal diagnosis of disseminated coccidioidomycosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B38.7 – Disseminated coccidioidomycosis

Disseminated coccidioidomycosis requires urgent medical intervention, often necessitating hospitalization for effective management.

Antibiotic Therapy:

• Fluconazole: 400-800 mg daily for 3-6 months.
• Itraconazole: 200 mg daily, duration varies based on response.
• Amphotericin B: For severe cases, administered intravenously.

Supportive Care:

• Hydration and electrolyte management.
• Symptomatic treatment for fever and pain.
• Monitoring for complications such as meningitis.

Infection Control:

• Implement standard precautions to prevent transmission.
• Educate healthcare staff on handling infected patients.
• Isolate patients with severe disseminated disease if necessary.

How to Document Symptoms of Disseminated coccidioidomycosis (ICD-10 B38.7) in SOAP Notes

Subjective:

• Patient reports persistent fever and chills.
• Complaints of cough and chest pain.
• History of recent travel to endemic areas.
• Neurological symptoms including headache and confusion.

Objective:

• Fever of 101°F on examination.
• Wheezing and decreased breath sounds on auscultation.
• Skin examination reveals erythematous lesions.
• Neurological exam shows altered mental status.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Disseminated coccidioidomycosis (ICD-10 Code B38.7)

Assessment:

• Disseminated coccidioidomycosis, severe.
• ICD-10 Code B38.7.
• Recent travel to endemic region identified as a risk factor.
• Immunocompromised status noted.

Plan:

• Initiate fluconazole therapy at 400 mg daily.
• Provide education on disease transmission and prevention.
• Monitor vital signs and neurological status closely.
• Schedule follow-up in one week to assess treatment response.

Treatment & Plan Section for ICD-10 Code B38.7 – Disseminated coccidioidomycosis

• First-line treatment includes fluconazole or itraconazole.
• Consider amphotericin B for severe cases requiring hospitalization.
• Educate patients on recognizing symptoms of worsening disease.
• Regular follow-up appointments to monitor treatment efficacy.

Using ICD-10 Code B38.7 for Disseminated coccidioidomycosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use B38.7 in conjunction with relevant procedure codes for billing.
• Maintain compliance with coding guidelines to support claims.
• Document any complications or comorbidities for comprehensive billing.

Related ICD-10 Codes Often Used with Disseminated coccidioidomycosis

• B38.0 – Coccidioidomycosis, unspecified
• B38.1 – Coccidioidomycosis, pulmonary
• B38.2 – Coccidioidomycosis, cutaneous
• B38.3 – Coccidioidomycosis, meningeal

ICD-10 Code B38.7 in Medical Billing and Insurance for Disseminated coccidioidomycosis

ICD-10 Code B38.7 is critical for billing in hospital, ER, or infectious disease settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use B38.7 in the primary diagnosis field for accurate billing.
• Include detailed notes on treatment plans and patient education.
• Ensure compliance with payer-specific guidelines for coding.

Common CPT Pairings: